The peripheral intravenous catheter (PIVC) is a small flexible tube inserted into a peripheral vein to deliver medicines and nutritional supplements. It is also used to collect blood samples for diagnostic purpose. The peripheral intravenous (IV) catheters are of two types, namely, short peripheral intravenous catheters (PIVCs) and integrated/closed catheters (PIVCs). Short PIVCs are further segmented into ported short PIVCs and non-ported short PIVCs.
Technavio’s analysts forecast the global peripheral intravenous (IV) catheter market to grow at a CAGR of 6.73% during the period 2017-2021.
Covered in this report The report covers the present scenario and the growth prospects of the global peripheral intravenous (IV) catheter market for 2017-2021. The report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.
The market is divided into the following segments based on geography: • Americas • APAC • EMEA
Technavio’s report, Global Peripheral Intravenous (IV) Catheter Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors • B. Braun Melsungen • BD • C.R. Bard • Smiths Medical • TERUMO CORPORATION
Other prominent vendors • AngioDynamics • APEXMED International • Delta Med • EXELINT International • GaltNeedleTech • Global Medikit • Hospira • NIPRO Medical • RenovoRx • Retractable Technologies • Teleflex • Vigmed • Vygon
Market driver • Increase in number of hospitalizations • For a full, detailed list, view our report
Market challenge • Complications associated with PIVCs • For a full, detailed list, view our report
Market trend • Increasing popularity of integrated/closed PIVCs • For a full, detailed list, view our report
Key questions answered in this report • What will the market size be in 2021 and what will the growth rate be? • What are the key market trends? • What is driving this market? • What are the challenges to market growth? • Who are the key vendors in this market space?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Our reports have been used by over 10K customers, including:
248 pages •
By Asia Market Information & Development Company
• May 2021
China’s demand for Drug Delivery System has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption...
The Asia Pacific Wearable Injectors market is expected to reach US$ 2939.97 million by 2027 from US$ 1160.40 million in 2019. The market is estimated to grow at CAGR of 12.4% from 2020 to 2027. The growth of the market is driven by the factors such as, increasing chronic diseases prevalence, technological advancements and design development,...
The Europe wearable injectors market is expected to reach US$ 3586.82 million in 2027 from US$ 1539.88 million in 2019. The market is estimated to grow with a CAGR of 11.3 % from 2020 to 2027. The growth of the market is driven by the factors such as, increasing chronic diseases prevalence, technological advancements and design development,...
The North America wearable injectors Market is projected to reach US$ 5767.51 million by 2027 from US$ 2370.52 million in 2019. The market is estimated to grow at CAGR of 11.9% from 2020 to 2027. The growth of the market is driven by the factors such as, increasing chronic diseases prevalence, technological advancements and design development,...
Rising prevalence for chronic diseases and growth in the biologics market are expected to drive the overall growth of the pharmaceutical drug delivery market. The global pharmaceutical drug delivery market is projected to reach USD 2,015.3 billion by 2025 from USD 1,430.5 billion in 2020, at a CAGR of 7.1% during the forecast period 2020-2025....
510 pages •
By Roots Analysis Private Ltd.
• May 2020
Chronic diseases, such as diabetes, cardiovascular disorders, neurological disorders, autoimmune disorders and various types of cancer, are known to be the leading causes of death and disability across the world. The clinical conditions associated with these diseases affect patients’ overall quality of life....
Increasing demand from drug delivery and catheters and cannulas to drive the overall growth of the medical tubing market The US medical tubing market size is expected to grow from USD 2.6 billion in 2020 to USD 2.9 billion by 2021, at a CAGR of 13.2% during the forecast period. The medical tubing industry is driven by various...
The liposome drug delivery market is expected to reach US$ 6,992.95 million by 2027 from US$ 3,594.41 million in 2019. The market is estimated to grow at a CAGR of 8.8% from 2020 to 2027.
The growth of the market is attributed to a few key driving factors such as increasing prevalence of chronic diseases, growing demand for noninvasive...
The bioresorbable medical material was valued at US$ 935.99 million in 2019 and is expected to grow at a CAGR of 9.7% from 2020 to 2027 to reach US$ 1,942.13 million by 2027. Driving factors of the bioresorbable medical material market are rising adoption of bioresorbable polymers for medical use and increasing number of orthopedic...
The electronic drug delivery systems market is projected to grow at a CAGR of 8.7% during the forecast period (2019–2024). The electronic drug delivery systems market is projected to reach USD 11.9 billion by 2024 from USD 7.8 billion in 2019, at a CAGR of 8.7%. The growth of the electronic drug delivery systems market...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.